Figure 4
Forest plots for multivariable analyses for mitral regurgitation improvement.* Abbreviations: BB, beta-blocker; LVEDD, left ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction; T-TEER, tricuspid transcatheter edge-to-edge repair; TR, tricuspid regurgitation. *: only variables with P < 0.300 are shown. The multivariable analyses included the following covariates: pre-discharge: baseline LVEF < 30%, baseline LVEDD > 60 mm, baseline TAPSE < 17 mm, acute procedural success, T-TEER, orthotopic replacement, beta-blocker therapy, atrial fibrillation; 2-month follow-up: baseline LVEDD > 60 mm, baseline LVEF < 30%, baseline TAPSE < 17 mm, TR reduction to at least moderate degree, acute procedural success, T-TEER, beta-blocker therapy.

Forest plots for multivariable analyses for mitral regurgitation improvement.* Abbreviations: BB, beta-blocker; LVEDD, left ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction; T-TEER, tricuspid transcatheter edge-to-edge repair; TR, tricuspid regurgitation. *: only variables with P < 0.300 are shown. The multivariable analyses included the following covariates: pre-discharge: baseline LVEF < 30%, baseline LVEDD > 60 mm, baseline TAPSE < 17 mm, acute procedural success, T-TEER, orthotopic replacement, beta-blocker therapy, atrial fibrillation; 2-month follow-up: baseline LVEDD > 60 mm, baseline LVEF < 30%, baseline TAPSE < 17 mm, TR reduction to at least moderate degree, acute procedural success, T-TEER, beta-blocker therapy.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close